HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alba Santos García Selected Research

Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)

9/2021Single rituximab dose as treatment for membranoproliferative glomerulonephritis relapse after kidney transplant.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alba Santos García Research Topics

Disease

2Pneumonia (Pneumonitis)
05/2022 - 01/2021
1Thrombocytopenia (Thrombopenia)
10/2023
1Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
09/2021

Drug/Important Bio-Agent (IBA)

1Heparin (Liquaemin)FDA LinkGeneric
10/2023
1Rituximab (Mabthera)FDA Link
09/2021

Therapy/Procedure

2Kidney Transplantation
05/2022 - 01/2021